title: Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics.
abstract: Hepatitis B virus (HBV) evades, subverts, activates and regulates host immune components, thereby impacting its natural history and disease pathogenesis. Recent advances in our understanding of immune interactions in chronic viral infection and tumor therapy are applicable to chronic hepatitis B (CHB). With recent successes of tumor immunotherapy, there is a renewed interest in exploring immunotherapeutics in achieving sustained and functional cure of chronic hepatitis B. In this review, we discuss aspects of host innate and adaptive immune regulatory and pathogenic responses relevant for HBV infection. We also highlight several immune modulatory approaches in clinical development to treat CHB.
authors: University of Pennsylvania Perelman School of Medicine, USA; Philadelphia Corporal Michael J. Crescenz VA Medical Center, USA. Electronic address: kmchang@mail.med.upenn.edu.
authors: Kyong-Mi
authors: KM
authors: Chang
authors: University of Pennsylvania Perelman School of Medicine, USA.
authors: Mengfei
authors: M
authors: Liu
mesh_terms: D056704:Adaptive Immunity; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D006515:Hepatitis B virus / Q000276:immunology*; D019694:Hepatitis B, Chronic / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007113:Immunity, Innate; D007167:Immunotherapy / Q000379:methods*
chemical_list: D000998:Antiviral Agents